Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06189092

Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study

Sponsor: Istituto Ortopedico Rizzoli

View on ClinicalTrials.gov

Summary

Venous malformations (MVs) are congenital abnormalities of the central or periphery caused by developmental errors at different stages of embryogenesis. Histologically they are characterized by large, venous-like vascular spaces. Scleroembolization constitutes the most widespread method in the treatment of venous malformations allowing good results with low invasiveness. Currently, Bleomycin (and its derivatives) is among the most widely used sclerosing agents for slow-flowing vascular malformations (venous and lymphatic malformations) because of the low rate of local serious adverse events such as swelling, necrosis, and nerve injury compared with others.

Official title: Trattamento Delle Malformazioni Venose a Basso Flusso Con l'Elettroscleroterapia. Studio Osservazionale Prospettico

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

OBSERVATIONAL

Enrollment

65

Start Date

2023-10-28

Completion Date

2027-11-28

Last Updated

2024-10-29

Healthy Volunteers

No

Interventions

DRUG

Bleomycin

Using electroporation to infuse bleomycin in the lesion

Locations (1)

Istituto Ortopedico Rizzoli

Bologna, Emilia-Romagna, Italy